Cigarette smoking is associated with the development of inflammatory lung diseases representing major health problems worldwide. We hypothesized that the redox-regulating molecule thioredoxin-1 (TRX), which shows anti-inflammatory, antioxidative, and antiapoptotic effects, could be induced by cigarette smoke (CS) and contribute to protect against CS-induced inflammation and lung destruction. In an acute study, human TRX transgenic mice and C57BL6/J mice were exposed to mainstream CS for 3 days. In the lungs of CS-exposed mice, bronchial epithelial injury and bronchoalveolar lavage neutrophilia were observed. Oxidative stress and apoptosis were enhanced, and the expression of cytokines macrophage inflammatory protein-2 and tumor necrosis factor (TNF)-⣠was increased 15.3-and 2.4-fold, respectively. Compared with C57BL6/J mice, TRX-transgenic mice had significantly less inflammation, oxidative damage, and apoptosis, as well as decreased levels of matrix metalloprotease-12 mRNA and serum TNF-âŁ. When recombinant human TRX (40 g/body/day, 3 days) was injected i.p. into CS-exposed C57BL6/J mice, a significant effect to offer protection against CS-induced lung injury was observed through suppression of neutrophil influx. In the chronic study, TRXtransgenic mice and C57BL6/J mice were exposed to CS for 6 months. This chronic exposure caused pulmonary emphysema in C57BL6/J mice accompanying prominent infiltration of macrophages and neutrophils to lung. These pathological changes were significantly suppressed in TRX-transgenic mice. In conclusion, TRX induction ameliorated CS-induced lung inflammation and emphysema in mice. TRX-1 may therefore play a preventive or therapeutic role in lung inflammatory disorders such as chronic obstructive pulmonary disease.Cigarette smoke (CS)-associated diseases such as ischemic heart disease, diabetes mellitus, and pulmonary diseases are the major health problem. Among those, the most important is chronic obstructive pulmonary disease (COPD) because morbidity is high and increasing (Pauwels et al., 2001;Rabe et al., 2007). The pathology of COPD is characterized as inflammation of the airways and loss of alveolar structure. The development of COPD is associated with chronic smoking that cause chronic inflammation, oxidative stress, and proteolysis. CS induces the production of large numbers of reactive oxygen species (ROS), which disturb the balance between oxidants and antioxidants, promoting lung cell apoptosis and amplifying the inflammatory responses in the lungs (Rabe et al., 2007).The activation of alveolar macrophage by oxidants results in releasing of several inflammatory cytokines and chemotactic factors that recruit circulating inflammatory cells such as neutrophils, which are also a secondary source of ROS (Hautamaki et al., 1997;Ofulue et al., 1998). TNF-⣠is a well documented chemotactic factor that is activated by the macrophage metalloelastase MMP-12 in a CS-induced lung inflammation (Churg et al., 2003). The recruited neutrophils and activated alveolar macrophages...